bioAffinity Technologies Inc. (BIAF): Price and Financial Metrics

bioAffinity Technologies Inc. (BIAF): $1.58

-0.10 (-5.95%)

POWR Rating

Component Grades













Add BIAF to Watchlist
Sign Up

Industry: Biotech



in industry

BIAF Stock Price Chart Interactive Chart >

Price chart for BIAF

BIAF Price/Volume Stats

Current price $1.58 52-week high $15.55
Prev. close $1.68 52-week low $1.31
Day low $1.53 Volume 25,700
Day high $1.68 Avg. volume 1,524,053
50-day MA $1.97 Dividend yield N/A
200-day MA $0.00 Market Cap 4.31M

BIAF Latest News Stream

Event/Time News Detail
Loading, please wait...

BIAF Latest Social Stream

Loading social stream, please wait...

View Full BIAF Social Stream

Latest BIAF News From Around the Web

Below are the latest news stories about BIOAFFINITY TECHNOLOGIES INC that investors may wish to consider to help them evaluate BIAF as an investment opportunity.

bioAffinity Technologies Appoints Julie Anne Overton Director of Corporate Communications

SAN ANTONIO, February 13, 2023--bioAffinity Technologies announces commercialization team for innovative CyPath® Lung screening test for early-stage lung cancer.

Yahoo | February 13, 2023

bioAffinity Technologies Announces Publication of Results of Clinical Trial in Peer-Reviewed Journal Respiratory Research

SAN ANTONIO, January 24, 2023--bioAffinity Technologies announces publication of the results of its clinical trial for its CyPath® Lung cancer diagnostic in Respiratory Research.

Yahoo | January 24, 2023

bioAffinity Technologies Announces Notice to Award U.S. Patent Protecting Novel Compounds for Specific Delivery of Cancer Treatments

SAN ANTONIO, January 04, 2023--bioAffinity Technologies received Notice of Allowance for a U.S. patent protecting novel compounds for specific delivery of cancer treatments.

Yahoo | January 4, 2023

Argus Research Initiates Equity Research Report Coverage on bioAffinity Technologies, Inc. (NasdaqCM: BIAF)

Argus Research, an independent investment research firm, has launched Equity Research Report coverage on bioAffinity Technologies, Inc. (NasdaqCM: BIAF)

Yahoo | December 19, 2022

bioAffinity Technologies Expands Diagnostic Division with Promotions and New Hires to Strengthen Clinical Bench

SAN ANTONIO, December 15, 2022--bioAffinity Technologies, Inc. (NASDAQ: BIAF; BIAFW), a biotechnology company addressing the need for noninvasive diagnosis of early-stage cancer and diseases of the lung, as well as targeted cancer treatment, today announced that they have made a key promotion and additions to their staff.

Yahoo | December 15, 2022

Read More 'BIAF' Stories Here

BIAF Price Returns

1-mo -23.30%
3-mo -6.51%
6-mo -41.91%
1-year N/A
3-year N/A
5-year N/A
YTD -1.25%
2022 N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.6823 seconds.